Hematological Malignancies

SAR’579/IPH6101 Granted FDA Fast Track Designation for Hematological Malignancies

Source: Innate Pharma On June 6, 2023, the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ...